Evaluation of Neuroprotective Agents In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: A Systematic Review and Meta-analysis (P7-4.016)

Key Points

• The central aim is to assess the effectiveness and safety of neuroprotective agents in Acute Ischemic Stroke patients undergoing endovascular treatment.
• Systematic review and meta-analysis of neuroprotective agents like Edaravone-Dexborneol, uric acid, and NXY-059.
• Comparison of treatment outcomes with standard care in AIS patients.
• Evaluation of functional and cognitive outcomes from included studies.
• Neuroprotective agents showed improved functional outcomes in patients undergoing endovascular treatment.
• Cognitive profiles were positively impacted by certain neuroprotective agents compared to standard treatment.
• Safety profiles of neuroprotective agents indicated no significant adverse effects in AIS patients.